Entry |
|
Name |
Efferocytosis - Nipponia nippon (crested ibis) |
Class |
Cellular Processes; Transport and catabolism
|
Pathway map |

|
Organism |
Nipponia nippon (crested ibis) [GN: nni]
|
Gene |
104010208 | CREB1; cyclic AMP-responsive element-binding protein 1 isoform X1 [KO:K05870] |
104010304 | VPS41; vacuolar protein sorting-associated protein 41 homolog isoform X1 [KO:K20184] |
104010665 | VPS8; LOW QUALITY PROTEIN: vacuolar protein sorting-associated protein 8 homolog [KO:K20178] |
104011197 | SLC2A1; solute carrier family 2, facilitated glucose transporter member 1 [KO:K07299] |
104011593 | PQLC2L; putative uncharacterized protein C3orf55 homolog [KO:K23678] |
104011627 | VPS16; vacuolar protein sorting-associated protein 16 homolog [KO:K20180] |
104011942 | ABCA1; LOW QUALITY PROTEIN: ATP-binding cassette sub-family A member 1 [KO:K05641] |
104012087 | ELMO1; engulfment and cell motility protein 1 isoform X1 [KO:K12366] |
104013097 | NFATC2; nuclear factor of activated T-cells, cytoplasmic 2 [KO:K17332] |
104013179 | PPARD; LOW QUALITY PROTEIN: peroxisome proliferator-activated receptor delta [KO:K04504] |
104014118 | CD47; LOW QUALITY PROTEIN: leukocyte surface antigen CD47 [KO:K06266] |
104014199 | CAMK2A; calcium/calmodulin-dependent protein kinase type II subunit alpha isoform X1 [KO:K04515] [EC:2.7.11.17] |
104014260 | TIMD4; T-cell immunoglobulin and mucin domain-containing protein 4 [KO:K26936] |
104014431 | ARNT; aryl hydrocarbon receptor nuclear translocator isoform X1 [KO:K09097] |
104015299 | GULP1; PTB domain-containing engulfment adapter protein 1 isoform X1 [KO:K23285] |
104015925 | LRP1; prolow-density lipoprotein receptor-related protein 1 [KO:K04550] |
104016069 | ADAM9; disintegrin and metalloproteinase domain-containing protein 9 [KO:K06834] [EC:3.4.24.-] |
104016115 | ATP2A3; LOW QUALITY PROTEIN: sarcoplasmic/endoplasmic reticulum calcium ATPase 3 [KO:K05853] [EC:7.2.2.10] |
104016213 | VPS11; vacuolar protein sorting-associated protein 11 homolog [KO:K20179] |
104016382 | BCAR1; breast cancer anti-estrogen resistance protein 1 [KO:K05726] |
104016462 | NFATC3; nuclear factor of activated T-cells, cytoplasmic 3 [KO:K17333] |
104016741 | SCARF1; LOW QUALITY PROTEIN: scavenger receptor class F member 1 [KO:K24318] |
104017050 | MEGF11; multiple epidermal growth factor-like domains protein 11 [KO:K24068] |
104019257 | MEGF10; multiple epidermal growth factor-like domains protein 10 isoform X1 [KO:K24068] |
104019349 | TGFBRAP1; transforming growth factor-beta receptor-associated protein 1 [KO:K20177] |
104019537 | ATP2A2; LOW QUALITY PROTEIN: sarcoplasmic/endoplasmic reticulum calcium ATPase 2 [KO:K05853] [EC:7.2.2.10] |
104020360 | VPS18; vacuolar protein sorting-associated protein 18 homolog [KO:K20181] |
104020711 | VPS33A; vacuolar protein sorting-associated protein 33A [KO:K20182] |
104021875 | NFATC1; nuclear factor of activated T-cells, cytoplasmic 1 [KO:K04446] |
104022931 | PPARG; peroxisome proliferator-activated receptor gamma [KO:K08530] |
|
Compound |
C00019 | S-Adenosyl-L-methionine |
C04230 | 1-Acyl-sn-glycero-3-phosphocholine |
C06124 | Sphingosine 1-phosphate |
C15610 | Cholest-5-ene-3beta,26-diol |
|
Reference |
|
Authors |
Doran AC, Yurdagul A Jr, Tabas I |
Title |
Efferocytosis in health and disease. |
Journal |
|
Reference |
|
Authors |
Zhang J, Ding W, Zhao M, Liu J, Xu Y, Wan J, Wang M |
Title |
Mechanisms of efferocytosis in determining inflammation resolution: Therapeutic potential and the association with cardiovascular disease. |
Journal |
|
Reference |
|
Authors |
Kawano M, Nagata S |
Title |
Efferocytosis and autoimmune disease. |
Journal |
|
Reference |
|
Authors |
Mehrotra P, Ravichandran KS |
Title |
Drugging the efferocytosis process: concepts and opportunities. |
Journal |
|
Reference |
|
Authors |
Park SY, Kim IS |
Title |
Engulfment signals and the phagocytic machinery for apoptotic cell clearance. |
Journal |
|
Reference |
|
Authors |
Kojima Y, Weissman IL, Leeper NJ |
Title |
The Role of Efferocytosis in Atherosclerosis. |
Journal |
|
Related pathway |
|
KO pathway |
|